NATCO Pharma Q3 PAT up
For the nine-month period, the company posted a net profit of Rs ₹1,149.50 crore (Rs ₹1,477.40 crore) on a revenue of Rs ₹3,339 crore (Rs ₹3,208.50 crore).
For the nine-month period, the company posted a net profit of Rs ₹1,149.50 crore (Rs ₹1,477.40 crore) on a revenue of Rs ₹3,339 crore (Rs ₹3,208.50 crore).
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
